COVID-19 a pandemic which has changed all human made materialistic world and shown a face which has shattered every medical and technological aspects worldwide and left us to rethink and rearrange our medical infrastructure. The present world health concern involving the emergence and rapid spread of a novel Corona virus (COVID-19) has prompted the entire scientific community to consider and rethink how it can help to fight this growing viral pandemic.

Scientific Meditech is pleased to invite the molecular biology, virology and immunology related contributors across the globe on its "2^nd International Webinar on Vaccines & Immunology" which is scheduled Online (Webinar) during February 24-25, 2023.

Theme: Illuminating entire perspectives of Vaccines and Immunology: The Past, Present, and Future

This virtual Congress is organized by Scientific Meditech with world class leading scientists and experts from around the globe will join us online to share their knowledge, views on the current ground-breaking developments and discoveries in the field of virology, immunology and vaccines, including the front-runner COVID-19 vaccines.

The main focus and aim of the Vaccines 2023 is to promote efficient and quality research and real-world impact in an atmosphere of true international cooperation between biological scientists and biotech researchers by bringing together virology experts, immunology and molecular biology expert’s along with industrial CEO’s and pharma heads to discuss the latest developments and innovations in the fields of Vaccines.

The meeting will equip with Keynote speakers, plenary speakers, Invited speakers, and young research forum speakers with workshops and special sessions would be interested in listeners and this is the best platform and opportunity to reach the wide gathering of participants and experts from the Vaccines, virology & Immunology community. It provides an explicit platform for presentations that distributes vital information, meets with current and renowned scientists with the most recent techniques, developments, and the latest updates in Vaccines & Immunology are hallmarks of this conference.

Several specific topics will include: Clinical Immunology, Molecular Biology & Immunology, Immuno-Genetics & Immune Tolerance, Influenza and Respiratory Diseases, Immune Disorders, Protein Based Vaccines, and Veterinary Vaccines, HIV/AIDS Vaccines and Hepatitis Vaccines, Antibodies: Engineering & Therapeutics, Computational Biology, RNA/DNA Conflicts, Vaccination Advancement and Immunization, Vaccine Research & Development, Next-Generation Vaccine Delivery Technologies, Novel Approaches & New Trends in Vaccines Development and special aspects of Vaccines Safety and Efficacy. The Vaccines 2023 is unique in bringing the Virology and Immunology fields together in the field of Vaccines and Viral diseases.

This Webinar will provide a perfect platform addressing:

• Commendable talks by top-notch global academic and scientific research community
• Remarkable awards and global recognition to meritorious Young Researchers
• Global networking with various countries
• Novel techniques to benefit your research
• Global networking & business opportunities
• Exquisite platform for showcasing your products and global sponsorship

Important Notes
Webinar Date: February 24-25, 2023
Webinar Type: Online ( Zoom Meeting)
Time Zone: CDT: 08:00 AM (EDT: 09:00 AM | London: 02:00 PM | KST: 10:00 PM)

Scientific Meditech expresses its gratitude to all our wonderful Session Speakers, Delegates, Students, Media Partners and Associations for making the International Webinar on Vaccines and Virology, February 25-26, 2022 a grand success.

We would like to convey a warm gratitude and special thanks to below Plenary Speakers of Vaccines 2022, February edition.

Srđan Stankov, Pasteur Institute Novi Sad, Serbia

Mic McGoldrick, Global CMC Policy at Merck, USA

Zheng Zhu, Fujian Medical University, China

Michael Kishko, Sanofi Pasteur, USA

Albert J. Auguste, Virginia Polytechnic Institute and State University, USA

Yongjun Sui, National Institutes of Health, USA

Domenico Merante, Global Clinical Development, Switzerland

Zachary Hartman, Duke University, USA

Catherine N. Kibirige, Imperial College London, UK

With the grand success of International Webinar on Vaccines and Virology, February 25-26, 2022 | Webinar (Online Meeting), Scientific Meditech is proud to announce the "2^nd International Webinar on Vaccines and Immunology”, which will be held during February 24-25, 2023 as a Webinar (Online Meeting).

Let us meet again @ 2^nd International Webinar on Vaccines and Immunology, February 24-25, 2023 | Webinar (Online Meeting).

Speaker benefits at Vaccines 2023:

• Opportunity to Chair/Co-chair a session of your interest
• Speaker pages created in Google on your name would get worldwide acknowledgement
• Opportunity to get sponsorship for your projects
• Opportunity to moderate the webinar/conference
• Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows
• Speaker will be felicitated with Certificate                
• B2B meetings
• Certificate Accreditation by the International Organizing Committee (IOCM)

Track 1: Coronavirus (COVID-19) Vaccine Research

Track 2: Vaccine Immunology and Immunotherapy

Track 3: Emerging and Re-Emerging Infectious Diseases

Track 4: Cancer Vaccines & Immunotherapy

Track 5: Immuno-Genetics & Immune Tolerance

Track 6: Immune-disorders, Allergy & Asthma and Human Vaccines

Track 7: Epidemiology and Parasitology

Track 8: Influenza and Respiratory Diseases

Track 9: Protein Based Vaccines

Track 10: Veterinary Vaccines, HIV/AIDS Vaccines and Hepatitis Vaccines

Track 11: Antibodies: Engineering & Therapeutics

Track 12: Vaccines Safety, Efficacy & Clinical Trails

Track 13: Vaccines Pre-Clinical Validation to Clinical Trials

Track 14: DNA Vaccines and RNA Vaccines

Track 15: Next-Generation Vaccine Delivery Technologies

Track 16: Novel Approaches & New Trends in Vaccines Development

Track 17: Vaccines Safety and Efficacy

Track 18: Vaccination Advancement and Immunization

Track 19: Immunization for pregnant& Lactating women

USA Molecular biology enzymes and kits & reagents marketplace by way of product, 2014-2025 ($ billion)

Technological advancements in molecular biology enzymes, kits, and reagents are one of the elements contributing to increase. Producers constantly broaden advanced products with a goal to boom their share. These advanced merchandise intentions to ease studies processes by means of supplying enhanced performance and better precision. For example, in June 2015, thermo fisher scientific, Inc. (USA) launched the new clever digest kit, which changed into designed for biopharmaceutical and proteomic applications.

The kit turned into designed to generate splendid records with a substantially decreased pattern instruction time compared to traditional in-solution digestion techniques. Growing investments by means of pharmaceutical & biotechnology groups in research activities, increased availability of funds for academic & research establishments, and provision of compensation for molecular diagnostics are different massive factors propelling boom. Genetic data of an individual is tremendously exclusive, for this reason can't be shared. Genome sequencing aids in identification and remedy of various sicknesses & disorders. Globally, there are no powerful tools to at ease the genetic data of an individual. Genetic facts are out there to docs and insurance companies. These statistics is stored in a cloud database and can be utilized by researchers across the globe. Hence, lack of high-cease generation to save genetic records is probably to restrain growth inside the coming years.

Product insights

The kits and reagents segment dominated in phrases of sales percentage in 2016. Low charges of kits & reagents and their repeated use in everyday strategies are the most important factors driving this marketplace. This section is also expected to develop at the fastest price in the course of the forecast period. The kits and reagents marketplace are characterized by the presence of a huge wide variety of local and international manufacturers. The cost worried within the production of reagents is significantly low, which similarly aids the producers in growing superior products. Furthermore, these products are regularly utilized in numerous studies processes, which in addition augments their demand. The kits and reagents marketplace are also expected to develop on the fastest rate for the duration of the forecast period. The prepared availability of complete kits is one of the main elements contributing to this boom rate.

Furthermore, developing choice and adoption of molecular diagnostics is predicted to propel boom. The enzymes marketplace in the latest years has witnessed a tremendous growth attributable to the availability of latest thermostable enzymes that can be used and stored at various temperatures. In November 2014, New England biolabs, Inc. (USA) released Warmstart Rtx opposite transcriptase, a thermostable reverse transcriptase, designed particularly for detection of nucleic acid. The enzyme is reversibly inhibited at room temperature and may be activated at 40°c. This reversible Warmstart functionality allows researchers to set up reactions at room temperature without a historical past reverse transcriptase interest.